
- Shares of Sangamo Therapeutics (NASDAQ:SGMO) fell on Friday after the company's chief financial officer, Prathyusha Duraibabu, notified of her decision to resign, effective October 1.
- The resignation decision is in order to assume a senior leadership role with a privately-held